Present and Future State of Surgical Management in Breast Cancer

European Journal of Surgery

Volumn 162, Issue 2, 1996, Pages 87-91

  Van Dongen, J A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; FEMALE; FUTUROLOGY; GENE; HUMAN; MASTECTOMY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, RADICAL; MASTECTOMY, SEGMENTAL; SURGICAL FLAPS; TAMOXIFEN;

EID: 1842530075     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Arnez Z, Smith R, Eder R. Breast reconstruction by the free lower transverse rectus abdominis muscular cutaneous flap. Br J Plast Surg 1988; 41: 500-507.
2. Bergman L, Dongen JA van, Leeuwen F van. Should tamoxifen be a primary treatment choice for elderly breast cancer patients with loco-regional disease? Breast Cancer Research and Treatment 1994; in press.
3. Bonadonna G, Veronesi U, Brambilla C et al. Primary treatment for resectable breast cancer. Rec Res Cancer Res 1993; 127: 113-117.
4. Bradbeer JW. Kyngdon J. Primary treatment of breast cancer in elderly women with tamoxifen. Clin Oncol 1983; 9: 31-34.
5. Dongen JA van, Fentiman IS, Harris JR, et al. In situ breast cancer: The EORTC consensus meeting. Lancet 1989; 334: 25-27.
6. Dongen JA van, Holland R, Peterse JL, et al. Ductal carcinoma in situ of the breast, second EORTC consensus meeting. Eur J Cancer 1992; 28: 626-629.
7. Dongen JA van, Bartelink H, Fentiman IS, et al. Factors influencing local relapse and survival and results of salvage treatment after breast conserving therapy in operable breast cancer: EORTC trial 10801, Breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992; 28: 801-805.
8. Early Breast Cancer Triallists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992; 339: 1-15.
9. Early Breast Cancer Triallists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992; 339: 71-85.
10. Fentiman IS, Poole C, Tong D, et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer 1991; 27: 447-450.
11. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. New Engl J Med 1985; 312: 674-681.
12. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. New Engl J Med 1993; 328: 1581-1586.
13. Hall JM, Lee MK, Newmann B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-1689.
14. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985; 5: 17-25.
15. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of T15, T1-2 breast carcinomas. Implications for clinical trials of breast conserving surgery. Cancer 1985; 56: 979-990.
16. Holmberg L. Sector resection with and without radiotherapy in early breast cancer. Presentation of two ongoing prospective multicenter studies in Sweden, Uppsala/Örebro Breast Cancer Study Group. Acta Oncol 1989; 28: 927-929.
17. Hooning MJ, Dongen JA van, Went G. Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation. Neth J Surgery 1991; 43: 102-104.
18. Koning HJ de, Dongen JA van, Maas PJ van der. Changes in use of breast conserving therapy in years 1983-2000. In: Koning HJ. The effects and costs of breast cancer screening, thesis Rotterdam 1993: 67-77.
19. Limbergen E van, Rijnders A, Schueren E van der. Cosmetics evaluation of breast conserving treatment for mammary cancer (2). Quantative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiotherapy and Oncology 1989; 16: 253-267.
20. Maas PJ van der, Koning HJ de, Ineveld BM van, et al. The cost-effectiveness of breast cancer screening. Int J Cancer 1989; 43: 1055-1060.
21. Malkin F, Li FP, Strong LC, et al. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-1238.
22. Narod SA, Feuteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir GM. Familial breast-ovarian cancer locus on chromosome 17 q12-q23. Lancet 1991; 338: 82-83.
23. Nayfield SG, Karp JE, Ford LG, et al. Potential role of tamoxifen in prevention of breast cancer. J Nat Cancer Inst 1991; 83: 1450-1459.
24. Newman B, Austin MA, Lee M, King MC. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high risk families. Proc Nat Acad Sc USA 1988; 85: 3044-3048.
25. Peters WP, Ross M, Vredenburg H , et al. High dose chemotherapy and autologous bone marrow support as consolidation after standard dose adjuvant therapy for high risk primary breast cancers. J Clin Oncol 1993; 11: 1132-1143.
26. Powles TJ, Tillyer CR, Jones AL, et al. Prevention of breast cancer with tamoxifen - an update on the Royal Marsden Hospital pilot programme. Eur J Cancer 1990; 26: 680-684.
27. Solin LJ, Recht A, Fourquet A, et al. Ten year results of breast conserving surgery and definitive irradiation for intraductal carcinoma of the breasts. Cancer 1991; 68: 2337-2344.
28. Velde CJH van de. Preoperative chemotherapy in operable breast cancer; the influence of timing FEC in relation to surgery. Drugs 1993; 45 (suppl. 3): 31-37.
29. Wall E van der, Richel DJ, Kusumanto YH, et al. FEC Chemotherapy with dose intensive epirubicin as initial treatment in high risk breast cancer. Ann Oncol 1993, in press.
30. Zoetmulder FAN, Borger JH, Rutgers EJTh, et al. Breast conserving therapy in patients with relatively large (T2 T3) breast cancer by preoperative irradiation and myocutaneous LD flap reconstruction. A new technique in breast conservation. Eur J Cancer 1993; 29: 957-961.